Alzheimer’s disease (AD) is the most common form of dementia. However, the etiopathogenesis
of this devastating disease is not fully understood. Recent studies in rodents suggest …

Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline in …

Traumatic brain injury (TBI) is associated with brain volume loss, but there is little information
on the regional gray matter (GM) and white matter (WM) changes that contribute to overall …

Importance Converging evidence suggests that Alzheimer disease (AD) involves insulin
signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose …

Background Trimethylamine N-oxide (TMAO), a small molecule produced by the metaorganismal
metabolism of dietary choline, has been implicated in human disease pathogenesis, …

Objective: To examine whether engagement in physical activity might favorably alter the age-dependent
evolution of Alzheimer disease (AD)-related brain and cognitive changes in a …

… Koscik e , Asenath La Rue e , Sanjay Asthana a b , Barbara B. Bendlin a b … Barbara Bendlin
had full access to all of the data in the study and takes responsibility for the integrity of the …

Midlife may be an ideal window for intervention in Alzheimer's disease (AD). To determine
whether sleep is associated with early signs of AD neuropathology (amyloid deposition) in …

Structural brain change and concomitant cognitive decline are the seemingly unavoidable
escorts of aging. Despite accumulating studies detailing the effects of age on the brain and …

The Wisconsin Registry for Alzheimer's Prevention is a longitudinal observational cohort
study enriched with persons with a parental history (PH) of probable Alzheimer's disease (AD) …